Curriculum Vitae

February 2007

Heloise Anne PEREIRA
(405) 271-2422, x-58034
(405) 271-8774 (Fax)
E-Mail: anne-pereira@ouhsc.edu

Education	Professional Experience	Memberships	Teaching
Research	Publications	University Governance	Professional Service
Technology for Licensing

EDUCATION:

1982	Ph.D., (Immunopathology), Department of Pathology, University of Melbourne, Australia.
1976	B.Sc. Honours, (Immunology), Department of Pathology, University of Melbourne, Australia.
1975	B.Sc., (double major: Microbiology & Pathology), University of Melbourne, Australia.

PROFESSIONAL EXPERIENCE

2006	Chairman and Chief Scientific Officer — Biolytx Pharmaceutical Corp., Oklahoma City, OK
2005	President and Chief Scientific Officer — Biolytx Pharmaceutical Corp., Oklahoma City, OK
1999-present	Adjunct Associate Professor, Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK
1999-present	Adjunct Associate Professor, Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
1997-present	Associate Professor with tenure, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
1992-1997	Assistant Professor, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
1991-1992	Assistant Professor (R.T.), Department of Microbiology and Immunology, Emory University, Atlanta, GA.
1984-1990	Senior Research Associate, Department of Microbiology and Immunology, Emory University, Atlanta, GA.
1984	Research Officer, Department of Immunology, Royal Children's Hospital, Melbourne, Australia
1982-1983	Hospital Scientist, Department of Immunology, Royal Children's Hospital, Melbourne, Australia.
1977-1982	Ph.D. project conducted under the supervision of Dr. C. S. Hosking, Director of Immunology, Royal Children's Hospital, Melbourne, Australia. Thesis entitled “Opsonic Factors in Serum”.
1976	B.Sc. Honours Project. Thesis entitled “Opsonins in Normal Human Serum”.
1971-1982	Research Assistant (part-time), Department of Obstetrics and Gynaecology, University of Melbourne, Australia.

MEMBERSHIPS AND HONORS:

Professional and Scientific Memberships:

1998-present	Association for Research in Vision and Ophthalmology (ARVO)
1997-present	Honorary Member, Delta Chapter of Alpha Epsilon Lambda
1994-2003	Sigma Xi
1994-present	Shock Society
1994-1999	International Endotoxin Society
1992-present	Society for Leukocyte Biology
1992-present	American Society for Investigative Pathology
1990-present	American Association for the Advancement of Science
1986-present	American Society for Microbiology
1984-1990	American Association of University Women

Awards and/or Honors:

2006	On the Brink, Journal Record Award for Innovation
1999	Fred G. Silva Research Award, University of Oklahoma Health Sciences Center
1998	Established Investigator - American Heart Association
1994	Provost's Research Award for outstanding research to a Junior Faculty member, University of Oklahoma Health Sciences Center
1992-1994	University of Oklahoma Health Sciences Center, Faculty Leadership Program.
1990-1992	American Lung Association Research Award
1987	Travel Scholarship, Gordon Research Conference on Phagocytes, New Hampshire.
1977-1981	Commonwealth Postgraduate Research Award.
1977	B.Sc. (Hons). First Class Honours and First Place.

TEACHING ACTIVITIES:

University of Oklahoma Health Sciences Center

Course Development:

2003	Molecular Basis of Human Disease (BMSC 6121)
2001-2003	Proteins & Nucleic Acids (BMSC 6012, 6023), Cellular systems (BMSC 6047); Neurobiology (BMSC 6102); Systemic Biology (BMSC 6103), Immunology (BMSC 6032), Tumor Biology & Pharmaceutical Principles (BMSC 6122)
2001	Principles of Pathobiology, PATH 6024 (Graduate Level)
1998-2001	Integrative Biology, BMSC 6022, (Graduate Level)
1995	Principles of Pathobiology, PATH 6023 (Graduate Level)

Course Direction:

2003-present	Molecular Basis of Human Disease (BMSC 6121)
2003	Co-director, Neuroimmunology and Neuroinflammation (OCNS 6311)
2002-present	Principles of Pathobiology, (PATH 6024)
2002-2003	Co-director, Immunology subsection of GPiBS Course, (Immunology, BMSC 6032)
1999-2000	Immunology Subsection of Integrative Biology Course, (BMSC 6022)
1998	Basic Pathology for Residents
1995-2001	Principles of Pathobiology, PATH 6023 (Graduate Level)

Course Participation:

2005	Directed Readings in Physiology, PHYO 5960 (16 hrs)
2005	Integrity in Scientific Research, BMSC 5001 (1 hr)
2005	OCNS Journal Club (1 hr)
2004	Neurobiology of Disease, OCNS 6503
2004-present	Molecular Basis of Human Disease, BMSC 6121
2004-present	Neurobiology, BMSC 6101
2004-present	Neuroimmunology and Neuroinflammation, OCNS 6311
2002-2003	Systemic Biology, BMSC 6103
2001-2003	Advanced Immunology, MI 6843 (Graduate level) Department of Microbiology and Immunology
2000-2001	Integrative Biology, BMSC 6045 (Graduate level)
2000-2002	Histology (lecture on the Immune System to Medical and Dental Students), CELL 8121/CELL 5136
1999	Advanced Topics in the Molecular Biology of Human Disease (ZOO 4970)
1999	Inflammation - Special lecture to Residents (2 hr.)
1998	Microanatomy (lecture on the Immune System to Medical and Dental Students), CELL 8210/CELL 8004
1998	Integrity in Scientific Research, BMSC 5001
1995-2000	Principles of Pathobiology, PATH 6023 (Graduate Level)
1995-2000	Host Parasite Interactions, MI 6402 (Graduate Level) Department of Microbiology and Immunology

Emory University

Course Participation:

1991	Graduate students, Concepts of Immunology, MBIO 511.
1990	Graduate students, Physiology "Blood and Water" Course.
1987-1990	Second year medical students, Medical Microbiology and Immunology Labs.

course participation:

University of Melbourne

1977-1981

Medical students, medical technologists, and science students, Histopathology Labs

Postdoctoral Fellows & Residents:

University of Oklahoma Health Sciences Center

2000-2004	Melva Gonzalez, M.D., Universidad Autónoma de Nuevo León (UANL), Monterrey, Nuevo León, Mexico. Ph.D., University of Oklahoma Health Sciences Center American Heart Association – Oklahoma Affiliate, Postdoctoral fellow (2001-2003) NIH – Postdoctoral trainee (2003-2004) CURENT POSITION: Postdoctoral Fellow, Dept. of Microbiology & Immunology
1999	Atif Ahmed, M.D., Resident, Department of Pathology, University of Oklahoma Health Sciences Center. current position: Unknown
1997-1998	Saritha Chary-Reddy, Ph.D., Osmania University, Hyderabad, India current position: 3rd year resident, Orthodontics, University of Texas HSC at San Antonio, TX
1996-1999	Xin Ruan, M.D., Shandong Medical University, P. R. China American Heart Association-Oklahoma Affiliate, Postdoctoral Fellow (1996–1999) Current Position: D.O. Student, School of Optometry, Boston, MA
1995-1997	Max Cary, Ph.D., Kansas State University, Manhattan, KS, D.V.M., Ohio State University, Columbus, OH current position: Clinical Assistant Professor, University of Oklahoma Health Sciences Center, Division of Animal Resources
1995-1996	Fernando Alberdi, Ph.D., Royal Melbourne Institute of Technology, Melbourne, Australia current position: Patent Attorney, Michigan
1994-1996	Ramesh Hegde, Ph.D., University of Illinois at Urbana-Champaign, Urbana, IL current position: following his successful completion of an MBA – Marketing Analyst, Time Warner Cable, Dallas, TX
1994-1995	Doris Quintana, M.D., Department of Surgery, University of Oklahoma Health Sciences Center. H. Dale Collins Surgery Scholar current position: Surgeon, Private Practice, Albuquerque, New Mexico

residency training program:

University of Oklahoma Health Sciences Center

Basic Immunology training during Immunopathology rotation

2000	Eric Thompson, M.D.
1999	Atif Ahmed, M.D.
1998	Steve Gorombey, M.D. Shi-Ping Jiang, M.D. James Smith, M.D.
1997	Jeffrey Gofton, M.D. Kyle Brantley, M.D.
1996	Jennifer O'Dell, M.D. John S. Vogel, D.O. John Markland, M.D. Ayumi Corn, M.D.
1995	Sheila Lynam, M.D. Jean Forsberg, M.D. Marty Malahy, M.D.
1994	Tom Cannon, M.D. Deborah Lastrapes, M.D. Michael McCormick, M.D.
1993	Elizabeth Gillies, M.D. Jennifer Dietrich, M.D.

graduate students:

2006-present	Jonathan Hunt, exam and PhD thesis committee
2006-present	Chris Robinson, exam and PhD thesis committee
2006	Kevin Burns, PhD rotation
2006	Anuradha Pradnis, PhD rotation
2006-present	Jeff Griffitts, PhD thesis committee
2005-present	Andrea Moyer, PhD thesis committee
2005-present	Brandt Wiskur - PhD thesis committee
2005	Lerin Luckett - PhD rotation
2005-present	Narcis Popescu
2005-present	Hari Vittal Rao
2004-present	Mingyuan Wu - PhD thesis committee
2004-present	Shannon Maier - PhD thesis committee
2003	Casie Soltani - PhD rotation
2002-2005	Cherie Chappell – M.S. major advisor
2002-present	Rebecca Schneider – Ph.D. thesis committee
2002-present	Eric Brown – Ph.D. thesis committee
2002	Dianca Graham – Ph.D. rotation
2002-present	Ling Guo – Ph.D. thesis committee
2002-present	Anuradha Pradhan – Ph.D. thesis committee
2001-present	Jamee Nixon – Ph.D. thesis committee
2001-2004	Khaldun Al-Khatib – Ph.D. thesis committee
2001	Andrew Ralph - Ph.D. rotation
2001	Lance Bridges - Ph.D. rotation
2001	Gui Yuan Li - Ph.D. rotation
2000-2003 2000-2002 2000-2004 2000-2004	Jennifer Xiao - Ph.D. thesis committee Micah McClain - M.D., Ph.D. thesis committee Grant Kolar - M.D., Ph.D. thesis committee Heather Hickman - Ph.D. thesis committee
1999-2001	Kajetan H. Groicher - Ph.D. thesis committee
1998-2000	Kasie Nichols - Ph.D. thesis committee
1998-2000	Melissa Arbuckle - Ph.D. thesis committee
1997-2000	Sean Bauman - Ph.D. thesis committee
1995-2001	Taunia Lee - Ph.D. Major advisor Current Position: Postdoctoral fellow, NIH training grant, University of Southern California, Los Angeles, CA
1995-1999	Qiuling Huang - Ph.D. thesis committee
1995-1998	Rachel He - M.S. Major advisor Current Position: Resident, Dept. of Pathology, University of Wisconsin
1995-1997	Kathryn Kelly - Ph.D. thesis committee
1994	Christine Roppelt - M.S. thesis committee
1994-1998	Hester Doyle - Ph.D. thesis committee
1994-1998	Anne Hamik, M.D., Ph.D. thesis committee
1993-1995	Zhao Ming Dong - Ph.D. thesis committee
1993	Janine North - Ph.D. rotation
1993	Qiuling Huang - Ph.D. rotation

undergraduate students:

2006	Alyssa Milam - Oklahoma Christian University, Edmond, Oklahoma
1996	Amy Veazey - Southern Nazarene University

summer students:

2006	Alyssa Milam - SURE - Oklahoma Christian University, Edmond, Oklahoma
2002	Naarah Gonzalez Current Position: Undergraduate, Brigham Young University, Utah
2000	DeAnna Williams-Oklahoma Center for NeuroScience (OCNS) Summer Intern Current Position: MS Health Administration, College of Public Health, OUHSC
1998	Lindsay Silva - (Bishop McGuinness High School)
1997	Sing Yiah Wong - SURE (Summer Undergraduate Research Experience) Program, Oklahoma City University
1996 1996	Lauren Kenney - (Bishop McGuinness High School) Vinod Kumar - (Oklahoma School)
1995	Laura McCloy - (Presbyterian-Harris Fellowship)
1995	Arun Sachdev - (Presbyterian-Harris Fellowship)
1995	Chad Hackaby - (Medical Student II, OUHSC)
1995	Colleen McInnis - (Summer Fellowship in Pathology)
1995	Shelley Amstutz - SURE (Summer Undergraduate Research Experience) Program
1994	Taunia Lee - SURE (Summer Undergraduate Research Experience) Program. Current Position: Postdoctoral fellow on NIH training grant, University of Southern California
1993	James Eng - Summer academy student Heather Saigo - SURE (Summer Undergraduate Research Experience) Program Radawn Mason - START Program.

mentorship program:

2006-2007	Alexandria Katie Maurer, Oklahoma School of Science and Mathematics (OSSM)
2006	Stefany Acosta-Torres , Oklahoma School of Science and Mathematics (OSSM)
2000-2001	Jessica Zaman, Oklahoma School of Science and Mathematics (OSSM) Current Position: Undergraduate Massachusetts Institute of Technology
1998-1999	Nazia Rahman, Oklahoma School of Science and Mathematics (OSSM) Current Position: Unknown
1995-1996	Kristine Turvey, Oklahoma School of Science and Mathematics (OSSM) Current Position: Unknown
1993-1994	Marian Meacham, Oklahoma School of Science and Mathematics (OSSM) Current Position: Unknown

Emory University

Postdoctoral Fellows:

1991-1992

Dr. Imre Erdem, Ege University, Turkey

Graduate Students:

1992	Rebecca McHugh, Ph.D. Rotation
1991	Kevin Pearce, Ph.D. Rotation
1990	Kathy Soreng, Ph.D. Rotation
1989	Diane Day, Ph.D. Rotation

Undergraduate Students:

1990-1991	Terry Jones, Emory University, Honors student.
1990	Robert Dozier, Morehouse College, Atlanta, GA, on NIH Minority Research Program
1988	Ivor Braden, Atlanta University Center, ADAMHA-MARC Research Training Program.

Summer Students:

1987	Cindy Pace, Mays High School, Atlanta, Minority Scholarship Program
1986	Leesha Hadley, Mays High School, Atlanta, Minority Scholarship Program

RESEARCH:

Research Grants and Contracts:

Past Funding:
A monocyte-specific chemoattractant from human PMN
American Lung Association
07/01/90 - 06/30/92
Total direct cost: $35,000
Principal Investigator

CAP37, a natural antibiotic from human neutrophils
Presbyterian Health Foundation/Provost's Research Fund
01/01/94 - 12/31/94
Total direct cost: $25,000
Principal Investigator

A Monocyte-specific chemoattractant from human PMN
NIH RO1, AI 28018
07/01/90 - 12/31/95
Total direct cost: $401,218
Principal Investigator

Monocyte-specific chemoattractant from human PMN
NIH, AI 28018-08
01/01/99 - 12/31/04
Total direct cost: $682,454
Principal Investigator

Experimental evaluation of a novel intervention for septic shock
Presbyterian Health Foundation
07/01/95 - 06/30/96
Total direct cost: $45,000
Co-investigator, Principal Investigator Daniel J. Brackett

Immunomodulation of monocytes by CAP37, a LPS-binding protein from PMN
American Cancer Society, IM 699A
07/01/93 - 12/31/96
Total direct cost: $356,106
Principal Investigator

CAP37, a mediator of atherosclerosis?
Oklahoma Center for the Advancement of Science and Technology, (OCAST) HR4-023
06/94 - 05/97
Total direct cost: $105,000
Principal Investigator

Monocyte-specific chemoattractant from human PMN
Presbyterian Health Foundation
10/01/96 - 09/30/97
Total direct cost: $44,650
Principal Investigator

Effect of CAP37, a neutrophil-derived inflammatory mediator on monocyte-endothelial interactions-
American Heart Association - Oklahoma Affiliate, 9707787S
07/01/97 - 06/30/00
Total direct cost: $95,457
Principal Investigator
Grant relinquished on 12/31/97 to accept Established Investigator Grant from the American Heart Association national office.

CAP37, an inflammatory mediator in Alzheimer's disease
Alzheimer's Association, IIRG-95-069
07/01/95 - 06/30/98
Total direct cost: $136,365
Principal Investigator

Septic Shock and Tissue Injury
NIH Postdoctoral Training Grant #2 T32 GM08237-06A1
07/01/94 - 06/30/98
Total direct cost: $424,000
Collaborator; Principal Investigator, Gary Kinasewitz, M.D.

Effect of CAP37, a neutrophil-derived inflammatory mediator on monocyte-endothelial interactions
American Heart Association - National Established Investigator Grant, 9740193N
01/01/98 - 12/31/01
Total direct cost: $272,728
Principal Investigator
Grant relinquished 12/31/98 to accept NIH AI28018-05A2

Modulation of Smooth Muscle Cell Function by CAP37, a Multifunctional Inflammatory Mediator
American Heart Association Postdoctoral Fellowship/Oklahoma Affiliate, 9604604S
07/01/96 - 06/30/99
Total direct cost: $71,172
Principal Investigator - Xin Ruan, M.D.
Sponsor- H. Anne Pereira, Ph.D.

Evaluation of a Novel Lipopolysaccharide Binding Intervention for Sepsis
VA - Merit Award
07/01/99 - 06/30/01
Total direct cost: $258,700
Principal Investigator - Daniel J. Brackett
Co-Investigator - H. Anne Pereira, Ph.D.

Endothelial-derived CAP37 (ECAP37): Characterization and Determination of its Role in Monocyte/Endothelial Interactions
AHA-Heartland Affiliate Predoctoral Fellowship, 9910132Z
07/01/99 - 06/30/01
Total direct cost: $32,000
Principal Investigator - Taunia D. Lee, M.S.
Sponsor - H. Anne Pereira, Ph.D.

Monocyte-specific chemoattractant from human PMN
NIH, AI 28018-07S1 Research Supplement for Underrepresented Minorities
08/15/00 – 12/31/02
Total direct cost: $34,316
Principal Investigator - H. Anne Pereira, Ph.D.
Minority Investigator – Melva L. Gonzalez, M.D., Ph.D.

Molecular Pathogenesis Training Grant
NIH Training Grant, 2T32 AI-07364-06
02/01/98 – 01/31/03
Total direct cost: $540,506
Principal Investigator - John Iandolo, Ph.D.
Preceptor - H. Anne Pereira, Ph.D.

CAP37, a novel inflammatory protein: Its role in the eye
OCAST
09/01/00 - 08/31/2003
Total direct cost: $135,000
Principal Investigator

CAP37, a new mediator of atherosclerosis?
American Heart Association – Heartland Affiliate – Postdoctoral Fellowship
07/01/01 – 06/30/03
Total direct cost: $70,124
Principal Investigator – Melva L. Gonzalez, M.D., Ph.D.
Sponsor – H. Anne Pereira, Ph.D.

Postdoctoral Hematology Research Training
NIH
06/30/04
Total direct cost: $699,365
Principal Investigator – G. Dale, Ph.D.
Collaborator – H. Anne Pereira, Ph.D.

CAP37 and ocular inflammation
Presbyterian Health Foundation
05/01/05 - 04/30/06
Total direct costs: $60,000
Principal Investigator - H. Anne Pereira, Ph.D.

Molecular Basis of Immunity
NIH Training Grant 1P32-AI07633-01A1
09/01/01-08/31/06
Total direct cost: $540,000
Principal Investigator - Madeleine Cunningham, Ph.D.
Collaborator& Steering Committee Member - H. Anne Pereira, Ph.D.

CAP37, a link between innate and adaptive immunity
Oklahoma Center for Advancement of Science and Technology (OCAST)
07/01/04–06/30/07
Total direct costs: $135,000
Principal Investigator – H. Anne Pereira, Ph.D.

Present Funding:

Molecular Basis of Immunity
NIH Training Grant T32-AI007633-06
09/01/06 - 08/31/11
Total direct cost: $211,352
Principal Investigator - Madeleine Cunningham, Ph.D.
Collaborator& Steering Committee Member - H. Anne Pereira, Ph.D.

CAP37, a mediator of neuronal interactions
Alzheimers' Association 11RG 05-13346
07/01/05–06/30/08
Total direct costs: $218,184
Principal Investigator – H. Anne Periera, Ph.D.

New therapeutics based on a natural antibiotic peptide
Oklahoma Center for Advancement of Science and Technology (OCAST)
Oklahoma Applied Research Support (OARS) program
03/01/06 - 02/28/08
Total direct costs: $256,047 from OCAST & $256,047 in matching funds; Total $512,094
Principal Investigator - H. Anne Pereira, Ph.D.
Co-Investigator - Gary Kinasewitz, M.D.

PAST Contract

Screening of CAP37 peptides for Antibacterial Activity
Biolytx Pharmaceuticals Corporation
12/1/05 - 11/30/06
Total costs: $12,316
Principal Investgiator – H. Anne Pereira, Ph.D.

PUBLICATIONS:

Peer Reviewed Articles:

Pereira, H.A., M.J. Shelton, & C.S. Hosking. Neutrophil iodination micro-method as an index of neutrophil and opsonic function. J. Clin. Lab. Immunol. 1983, 11:47-53.
Pereira, H.A. & C.S. Hosking. Serum opsonins of control children of different ages. Aust. Paediatr. J. 1983, 19:23-26.
Pereira, H.A. & C.S. Hosking. The role of complement and antibody in the opsonisation and intracellular killing of Candida albicans. Clin. Exp. Immunol. 1984, 57:307-314.
Vadas, M.A., N. Nicola, A.F. Lopez, D. Metcalf, G. Johnson, & H.A. Pereira. Mononuclear cell-mediated enhancement of granulocyte function in man. J. Immunol. 1984, 133:202-207.
Spitznagel, J.K., H.A. Pereira, L.E. Martin, G.S. Guzman, & W.M. Shafer. A monoclonal antibody that inhibits the antimicrobial action of a 57 kD cationic protein of human polymorphonuclear leukocytes. J. Immunol. 1987, 139:1291-1296.
Georgiou, G., D. Roberton, H.A. Pereira, B. Scaletti, G. Kannourakis, C. Hosking, & K. Fowler. A human complement fixing monoclonal antihuman lymphocyte antibody of rat origin. Immunol. Cell Biol. 1988, 66:33-42.
Pereira, H.A., L.E. Martin, & J.K. Spitznagel. Quantitation of a cationic antimicrobial granule protein of human polymorphonuclear leukocytes by ELISA. J. Immunol. Methods 1989, 117:115-120.
Pereira, H.A., J.K. Spitznagel, J. Pohl, D.E. Wilson, J. Morgan, I. Palings, & J.W. Larrick. CAP37, a 37kD human neutrophil granule cationic protein that shares homology with inflammatory proteinases. Life Sc. 1990, 46:189-196.
Pereira, H.A., W.M. Shafer, J. Pohl, L.E. Martin, & J.K. Spitznagel. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J. Clin. Invest. 1990, 85:1468-1476.
Pereira, H.A., J.K. Spitznagel, E.F. Winton, W.M. Shafer, L.E. Martin, G.S. Guzman, J. Pohl, R.W. Scott, M.N. Marra, & J.M. Kinkade, Jr. The ontogeny of a 57kD cationic antimicrobial protein of human polymorphonuclear leukocytes: Localization to a novel granule population. Blood 1990, 76:825-834. cover article
Pohl, J., H.A. Pereira, N. Moore-Martin, & J.K. Spitznagel. Amino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocyte-specific chemotactic glycoprotein structurally similar to neutrophil elastase. FEBS. Lett. 1990, 272:200-204.
Morgan, J.G., H.A. Pereira, T. Sukiennicki, J.K. Spitznagel, & J.W. Larrick. Human neutrophil granule cationic protein, CAP37 is a specific macrophage chemotaxin that shares homology with inflammatory proteinases. Adv. Exp. Med. Biol. 1991, 305:89-96.
Morgan, J.G., T. Sukiennicki, H.A. Pereira, J.K. Spitznagel, M.E. Guerra, & J.W. Larrick. Cloning of the cDNA for the serine protease homolog CAP37/azurocidin, a microbicidal and chemotactic protein from human granulocytes. J. Immunol. 1991, 147:3210-3214.
Pereira, H.A., I. Erdem, J. Pohl, & J.K. Spitznagel. Synthetic bactericidal peptide based on CAP37: A 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc. Natl. Acad. Sci. (USA). 1993, 90:4733-4737.
Pereira, H.A. CAP37, a neutrophil-derived multifunctional inflammatory mediator. J. Leukoc. Biol. 1995, 57:805-812.
Aragon, A.S., H.A. Pereira, & O.G. Baca. A synthetic bactericidal peptide based on the human neutrophil's antimicrobial CAP37 protein enhances Coxiella burnetti infection of host cells. Acta. Virologica. 1995, 39:223-226.
D'Cruz, O.J., H.A. Pereira, & G.G. Haas, Jr. Sperm immobilizing activity of a synthetic bioactive peptide 20-44 of 37kDa cationic antimicrobial protein of human neutrophils J. Andrology 1995, 16:432-440.
Pereira, H.A., P. Kumar, & P. Grammas. Expression of CAP37, a novel inflammatory mediator in Alzheimer's disease. Neurobiol. Aging 1996, 17:753-759.
Pereira, H.A., P. Moore, & P. Grammas. CAP37, A neutrophil granule-derived protein stimulates protein kinase C activity in endothelial cells. J. Leukoc. Biol. 1996, 60:415-422.
Brackett, D.J., M.R. Lerner, M.A. Lacquement, R. He, & H.A. Pereira. A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats. Infect. Immun. 1997, 65:2803-2811.
Polikandritou-Lambros, M., E. Sheu, J.S. Lin & H.A. Pereira. Interaction of a synthetic peptide based on the neutrophil-derived antimicrobial protein CAP37 with dipalmitolyl-phosphatidylcholine membranes. Biochim. Biophys. Acta. 1997, 1329:285-290.
Pereira, H.A. CAP37, a multifunctional inflammatory protein. J. Chinese Med. Assoc. 2001,114:9-13.
Lee, T.D., M.L.Gonzalez, P. Kumar, S. Chary-Reddy, P. Grammas & H.A. Pereira. CAP37, a novel inflammatory mediator: Its expression in endothelial cells and localization to atherosclerotic lesions. Amer J. Pathol. 2002, 160:841-848.
Ruan, X, J. Chodosh, M. Callegan, M. Booth, T. Lee, P. Kumar, M. Gilmore & H. A. Pereira. Corneal expression of the inflammatory mediator CAP37. Invest. Ophthalmol. Vis. Sci. 2002, 43:1414-1421.
Pereira, H.A., X. Ruan & P. Kumar. Activation of microglia: a neuroinflammatory role for CAP37 GLIA, 2003, 41:64-72.
T. Lee, M.L. Gonzalez, P. Kumar, P. Grammas, & H.A. Pereira. CAP37, an inflammatory mediator augments leukocyte adhesion to endothelial monolayers. Microvasc. Res. 2003; 66:38-48
Pereira HA, Ruan X, Gonzalez ML, Tsyshevskaya-Hoover I, and Chodosh J. Modulation of corneal epithelial cell functions by the neutrophil-derived inflammatory mediator CAP37. Invest Ophthalmol Vis Sci. 2004; 45:4284-92.
Gonzalez ML, Ruan X, Kumar P, Grammas P, and Pereira HA. Functional modulation of smooth muscle cells by the inflammatory mediator CAP37. Microvasc Res. 2004; 67:168-81.
Pereira HA. Novel therapies based on cationic antimicrobial peptides. Current Pharmaceut Biotechnol. 2006; 7:229-234.
Pereira HA, Tsyshevskaya-Hoover I, Hinsley H, Logan S, Nguyen M, Pohl J, Wozniak K, and Fidel PL, Jr. Candidacidal activity of synthetic peptides based on the antibiotic domain of the neutrophils-derived protein, CAP37. Infec Immun. 2006 (In revision-IA101641-06).
Reining G, Lassnigg A, Pereira HA, & Wagner L. CAP37 during cardiopulmonary bypass. Increase in plasma levels upon heparin and low molecular weight heparin administration in humans. 2004. (Submitted)
Gordon YJ, Romanowski EG, Yates KA, Pereira HA. Peptides derived from CAP37, a cationic antimicrobial protein, have direct antiviral activity in vitro against adenovirus and herpes simplex virus-1. Curr. Eye Res. 2006 (In revision Cell5gg06).

Books/Chapters:

Larrick, JW, Pereira HA, Spitznagel JK, Sukiennicki T, & Morgan J.G. CAP37: A monocyte-specific chemotaxin released from the azurophilic granules of polymorphonuclear leukocytes. In, Cellular and Cytokine Networks in Tissue Immunity, eds., M. Meltzer & A. Mantovani, Wiley-Liss Inc., New York 1991, 319-324.
Spitznagel JK & Pereira HA. Antibiotic proteins of human neutrophils: Interaction with the surface of Salmonella. In, The Biology of Salmonella. Eds. F. Cabello & C Hormaeche. Plenum Press. NATO ASI series, Series A Life Sciences 1993, 245:149-158.
Pereira HA. Assay systems for measurement of chemotactic activity. In, Methods in Molecular Biology. Antibacterial Peptide Protocols. ed. W.M. Shafer, Humana Press Inc., New Jersey 1997, 78:233-246.
Brackett DJ, Lerner MR, & Pereira HA. Neutralization of the in vivo activity of E. coli-derived lipopolysaccharide by cationic peptides. In Methods in Molecular Biology. Antibacterial Peptide Protocols. ed. W.M. Shafer, Humana Press Inc., New Jersey 1997, 78:247-255.
Pereira HA, Kuman P, Lerner MR, and Brackett DJ. Inducible expression of the inflammatory protein CAP37 in the epidermis during wound healing. Focus on Protein Res. ed. J.W. Robinsion, 2004, ch 6, pp. 133-148.

Abstracts:

Pereira, H.A. & J.K. Spitznagel. The immunocytochemical localization of a 57kD cationic protein (CAP57) in polymorphonuclear leukocytes: A phylogenetic study. 18th Annual Southeastern Immunology Conference. October 10, 1985, Stone Mountain, GA.
Pereira, H.A., W.M. Shafer, & J.K. Spitznagel. Monoclonal antibodies to an epitope of a 57KD cationic protein of human neutrophils associated with antimicrobial activity. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 29, 1986, New Orleans, LA.
Pereira, H.A., E.F. Winton, & J.K. Spitznagel. Ontogeny and phylogeny of a cationic antimicrobial granule protein of human polymorphonuclear leukocytes (PMNs): An immunocytochemical study. 6th International Congress of Immunology. July 6, 1986, Toronto, Canada.
Roberton, D., G. Georgiou, H.A. Pereira, B. Scaletti, H. Zola, G. Pilkington, & C. Hosking. A rat monoclonal antihuman lymphocyte antibody which is cytotoxic with human complement. 6th International Congress of Immunology. July 6, 1986, Toronto, Canada.
Pereira, H.A. & J.K. Spitznagel. Neutrophil (PMN) granules deliver a 57kD cationic antimicrobial protein (CAP57) to S. typhimurium, S. aureus, E. coli and C. albicans during phagocytosis. American Society for Microbiology. March 1, 1987, Atlanta, GA.
Pereira, H.A., J.K. Spitznagel, W.M. Shafer, & L.E. Martin. A novel neutrophil-derived chemotactic factor specific for monocytes. FASEB, 73rd Annual Meeting. March 19, 1989, New Orleans, LA. FASEB J. 1989, 3:3989.
Morgan, J.G., H.A. Pereira, J.K. Spitznagel, & J.W. Larrick. Cloning of CAP37 a monocyte-specific chemotactic factor released from azurophilic granules of polymorphonuclear leukocytes. 2nd International Workshop on Cytokines. December 10, 1989, Hilton Head, SC. Cytokine 1989, 1:32.
Pereira, H.A. & J.K. Spitznagel. CAP37, a monocyte specific chemoattractant. 29th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 17, 1989, Houston, TX.
Morgan J.G., H.A. Pereira, T. Sukiennicki, J.K. Spitznagel, & J.W. Larrick. Human neutrophil granule cationic protein, CAP37 is a specific macrophage chemotaxin that shares homology with inflammatory proteinases. 2nd International Symposium on Chemotactic Cytokines. June 25, 1990, London, U.K.
Larrick J.W., H.A. Pereira, J.K. Spitznagel, T. Sukiennicki, & J.G. Morgan. CAP37, a monocyte-specific chemotaxin released from azurophilic granules of polymorphonuclear leukocytes. International Conference on Leukocyte Biology. October 14, 1990, Crete, Greece. J. Leukoc. Biol. 1990, 48 (suppl) 287.
Pereira, H.A. & J.K. Spitznagel. CAP37, a neutrophil (PMN) granule-derived protein with monocyte specific chemotactic activity and lipopolysaccharide (LPS) binding activity. 3rd International Workshop on Cytokines. November 10, 1991. Stresa, Italy. Cytokine1991, 3:195.
Pereira, H.A. B. Moore, & P. Grammas. Protein kinase C activation in rat cerebral endothelial cells by CAP37, a neutrophil granule-derived cationic protein. Experimental Biology, March 28-April 1, 1993, New Orleans, LA. FASEB J. 1993, 7:714.
Pereira, H.A. I. Erdem, J. Pohl, & J.K. Spitznagel. CAP37, a multifunctional host defense and inflammatory protein: Identification of its chemotactic, antibiotic and endotoxin binding domains. American Society for Microbiology, May 16-20, 1993, Atlanta, GA.
Pereira, H.A. M. Lacquement, I. Erdem, J. Pohl, & J.K. Spitznagel. Identification of an antibacterial peptide based on the sequence of CAP37, a natural antibiotic and lipopolysaccharide binding protein from human neutrophils. Second Workshop on Pore-forming Toxins. September 29 - October 2, 1993, Mainz, Germany.
Pereira, H.A., R.A. Brumback, & P. Grammas. Cerebrovascular localization of CAP37 in Alzheimer's disease. Society for Neuroscience, November 7-12, 1993, Washington, DC. Soc. Neurosci. 1993, 19:692.
Polikandritou, M., E. Sheu, & H.A. Pereira. The effect of CAP37 on lipid membranes. The American Association of Pharmaceutical Scientists, November 14-19, 1993, Orlando, FL J. Amer. Assoc. Pharm. Sci. 1993, 10:S265.
Pereira, H.A. & J.K. Spitznagel. CAP37, a mediator of monocyte chemotaxis during the second wave of inflammation. International Congress on the Regulation of Leukocyte Production and Immune Function. December 1-5, 1993, Sydney, Australia. J. Leukoc. Biol. 1993 (suppl) 212.
Pereira, H.A., P. Moore, K. Sachen, & P. Grammas. CAP37, an inflammatory mediator that promotes both monocyte chemotaxis and leukocyte adhesion to endothelial cells. Keystone Symposium on Inflammation, Growth Regulatory Molecules and Atherosclerosis. January 16-23, 1994, Keystone Co. J. Cell. Biochem. 1994, 18A:297.
Pereira, H.A., M. Lacquement, & J.K. Spitznagel. CAP37, a multifunctional neutrophil protein with lipopolysaccharide (LPS) binding activity. 17th Annual Conference on Shock, June 5-8, 1994, Big Sky, Montana. Shock 1994, 1 (suppl) 116.
Brackett, D.J., M.R. Lerner, & H.A. Pereira. An LPS-binding peptide derived from the neutrophil-associated protein CAP37 prevents endotoxin induced hyper- and hypo-dynamic responses in the conscious rat. 17th Annual Conference on Shock, June 5-8, 1994, Big Sky, Montana. Shock 1994, 1 (suppl) 147.
D'Cruz, O.J., H.A. Pereira, & G.G. Haas. Sperm immobilizing activity (SIA) of a synthetic bioactive peptide (P20-44) of a 37kDa cationic antimicrobial protein (CAP37) of human polymorphonuclear leukocytes (PMN). American Society for Reproductive Immunology, June 22-25, 1994, Philadelphia, PA. Am. J. Reprod. Immunol. 1994, 31:515.
Pereira, H.A., M. Lacquement, & J.K. Spitznagel. CAP37, a multifunctional neutrophil protein with lipopolysaccharide (LPS) binding activity. 3rd Conference International Endotoxin Society, August 15-18, 1994, Helsinki, Finland. J. Endotox. Res. 1994, 1:C194.
Brackett, D.J., M.R. Lerner, & H.A. Pereira. An LPS-binding peptide derived from the neutrophil-associated protein CAP37 prevents endotoxin induced hyper- and hypo-dynamic responses in the conscious rat. 3rd Conference International Endotoxin Society, August 15-18, 1994, Helsinki, Finland. J. Endotox. Res. 1994, 1:C195.
Polikandritou, M. & H.A. Pereira. The thermodynamic effect of CAP37 on lipid membranes. American Association of Pharmaceutical Scientists (AAPS), November 14-19, 1994, San Diego, CA. J. Amer. Assoc. Pharm. Sci. 1994, 11:S326.
Pereira, H.A. & M. Lacquement. CAP37, a monocyte chemoattractant induces superoxide production. 7th Biennial International Society for Free Radical Research, November 6-10, 1994, Sydney, Australia. J. Free Rad. Biol. Med. 1994, 2:P01.
Lee, T., P. Kumar, M. Lacquement, P. Grammas, & H.A. Pereira. Cytokine induction of CAP37 in endothelial cells. 12th Annual Texas Regional Immunology Conference, November 11-13, 1994, Oklahoma City, OK.
Pereira, H.A., P. Kumar, T. Lee, M. Lacquement, & P. Grammas. Expression of CAP37 by cytokine-activated endothelial cells. Experimental Biology, April 9-13, 1995, Atlanta, GA. FASEB J. 1995, 9:213.
Hegde, R., P. Grammas, & H.A. Pereira. Effect of CAP37 on rat aorta endothelial and smooth muscle cell chemotaxis. Experimental Biology, April 9-13, 1995, Atlanta, GA. FASEB J. 1995, 9:3588.
Grammas, P., M. Kumar, & H.A. Pereira. Inflammatory mediator CAP37 inhibits nitric oxide synthase activity in rat brain endothelial cells. Experimental Biology, April 9-13, 1995, Atlanta, GA. FASEB J. 1995, 9:3451.
Grammas, P., T. Botchlet & H.A. Pereira. Effect of CAP37 on brain endothelial cell phosphatidyl choline (PC) hydrolysis. Society for Neuroscience, November 11-16, 1995, San Diego, CA. Soc. Neurosci. 1995, 21:1085.
Quintana, D.A., L. McCloy, M.R. Lerner, G. Wallis, S.A. Lightfoot, H.A. Pereira, P.B. McCay, D.J. Brackett, & L.R. Pennington. Prevention of ischemia/reperfusion – induced vasoconstriction and detection of increased nitric oxide (NO) production by in vivo spin-trapping combined with electron paramagnetic resonance spectroscopy during treatment with the NO donor nitroprusside. American College of Surgeons Surgical Forum. San Francisco CA, October 6-11, 1996.
Quintana, D.A., L. McCloy, M.R. Lerner, G. Wallis, S.A. Lightfoot, H.A. Pereira, P.B. McCay, D.J. Brackett, & L.R. Pennington. Prevention of ischemia/reperfusion-induced vasoconstriction and detection of increased nitric oxide (NO) production by in vivo spin-trapping combined with electron paramagnetic resonance spectroscopy during treatment with the NO donor nitroprusside. Association for Academic Surgery, Chicago, IL. November 13-16, 1996.
Pereira, H.A., P. Kumar, & P. Grammas. Effect of neutrophil-derived CAP37 on monocyte-endothelial interactions. Experimental Biology, April 6-9, 1997, New Orleans, LA. FASEB J. 1997:11(3), 603.
He, R., F. Alberdi, P. Kumar, R. Hegde, A.R. Rezaie, & H.A. Pereira. Expression and purification of recombinant CAP37 (rCAP37), a multifunctional inflammatory mediator. Experimental Biology, April 6-9, 1997, New Orleans, LA. FASEB J. 1997:11(3), 1915. [Student Travel Award Recipient, ASIP]
Pereira, H.A. CAP37, an endogenous antibiotic protein from human neutrophils. 2nd International Antibacterial Drug Discovery Summit, Princeton, NJ. March 24-25, 1997.
Pereira, H.A., P. Kumar, & L. Silva. Activation of microglia by CAP37, a multifunctional inflammatory mediator. Experimental Biology, April 17-21, 1999, Washington, D.C., faseb j., 1999:13(5), 401.
He, R., X. Ruan, & H. A. Pereira. Identification of specific binding sites on circulating monocytes for CAP37, a multifunctional inflammatory mediator. Experimental Biology, April 17-21, 1999, Washington, D.C., FASEB J., 1999:13(5), 643.14.
Ruan, X., M.C. Callegan, M. Booth, M. Gilmore, J. Chodosh, & H.A. Pereira. Expression of CAP37, a multifunctional inflammatory mediator, in corneal epithelial cells in a rabbit model of Staphylococcus aureus keratitis. ARVO, May 9-14, 1999, Fort Lauderdale, FL., IOVS, 1999:40(4), 1379.
Ruan, X., T. Lee, J. Chodosh, & H. A. Pereira. Induction and molecular cloning of CAP37, a novel inflammatory mediator from corneal epithelial cells. ARVO, April 30-May 5, 2000, Fort Lauderdale, FL., IOVS, 2000:41(4), 4811.
Ruan, X., D. Williams, & H. A. Pereira. CAP37 a novel inflammatory mediator that activates microglia and regulates chemokine induction. Decade of the Brain, Oklahoma Center for Neuroscience Symposium, Oklahoma City, OK, September 29, 2000.
Lee, T. D., P. Kumar, S. Chary-Reddy, P. Grammas, & H. A. Pereira. Demonstration of CAP37, a monocyte chemoattractant in endothelial cells. Experimental Biology 2001, March 31 – April 4, 2001, Orlando, FL., 2001:15(4), A393. [Student Travel Award Recipient, ASIP]
Ruan, X., J. Chodosh, & H. A. Pereira. CAP37, a multifunctional inflammatory mediator promotes corneal epithelial cell proliferation and migration. Brain Awareness Week, April 2001, Oklahoma City, OK. [Travel Award Recipient, Oklahoma Chapter for Neuroscience).
Ruan, X., J. Chodosh, & H. A. Pereira. CAP37, a multifunctional inflammatory mediator promotes corneal epithelial cell proliferation and migration. ARVO, May 2001, Fort Lauderdale, FL., IOVS, 2001:42(4), 4759.
Pereira, H. A., X. Ruan, D. Williams, & P. Kumar. The neuroinflammatory role of CAP37. The Cytokine Odyssey, Nov. 8-11, 2001, Maui, Hawaii. J. Leukoc. Biol. 2001 Suppl, A267.
Lee, T., M.L. Gonzalez, P. Kumar, & H.A. Pereira. CAP37, an inflammatory mediator augments leukocyte adhesion to endothelial monolayers. 19th Texas Regional Immunology Conference. Oklahoma City, OK November 9, 2001
Gonzalez, M.L., T.D. Lee, P. Kumar, & H.A. Pereira. Upregulation of adhesion molecules on endothelial cells by the neutrophil-derived inflammatory mediator CAP37. Experimental Biology 2002, New Orleans, LA, April 20-24. FASEB J. 2002, 16:A596
Pereira, H.A., X. Ruan & J. Chodosh. Modulation of corneal epithelial cell adhesion molecules by CAP37 an inflammatory mediator. ARVO, Fort Lauderdale, FL, May 2002. Invest. Ophthalmol. Vis. Sci. 2002, 43(4): 4201
Gonzalez, M.L., X. Ruan, P. Kumar, N. Gonzalez, P. Grammas, H.A. Pereira. Functional modulation of aortic smooth muscle cells by the inflammatory mediator CAP37. Experimental Biology 2003, San Diego, CA April 11-15. [Postdoctoral Travel Award].
Pereira, H. A., M.L. Gonzalez, X. Ruan, M.R. Lerner, D.J. Brackett. Differential gene expression in human corneal epithelial cells (HCEC) in response to the inflammatory mediator, CAP37. ARVO, Fort Lauderdale, FL, May 2003.
Pereira HA, Kumar P, Cary M, and Pohl J. Novel synthetic peptides based on CAP37 protect mice from lethal Salmonella infection. 43^rd ICAAC, Chicago, IL, September 2003.
Tsikitis VL, Janowski JW, Lee C, Cioffi WG, Pereira HA and Reichner JS. Autocrine regulation of endothelial function. 66th Annual Society of Surgeons, Nashville, TN, February 2005.
Dunican A, Janowski JW, Lee C, Cioffi WG, Pereira HA and Reichner JS. Boiphasic regulation of endothelial barrier function. 66th Annual Society of Surgeons, Nashville, TN, February 2005.
Gordon VJ, Romanowski EG, Yates KA and Pereira HA. Human CAP37, a cationic protein, demonstrates direct antiviral activity against adenovirus types 3 and 5 and herpes simplex virus in vitro. ARVO, Ft Lauderdale, FL, May 2005.
Pereira , H.A. , I. Hoover , J. Pohl and P.L. Fidel, Jr. Candidacidal activity of synthetic peptide analogs of the neutrophil-derived antimicrobial peptide, CAP37. 45 th ICAAC, Washington, DC, December 2005.
Pereira , H.A. , Hoover , I., Hinsley, H., Logan , S., Nguyen, M., Pohl, J. and P.L. Fidel, Jr. Novel candidacidal activity by cationic antimicrobial protein CAP37 peptides. 8 th American Society for Microbiology (ASM) Conference on Candida and Candidiasis. Denver, CO, March 13-17, 2006
Hansen, H.A., Tsikitis, V.L., Janowski, J.W., Lee, C., Pereira , H.A. and J.S. Reichner. Autocrine regulation of endothelial cell function by CAP37. Experimental Biology EB 2006, San Francisco, CA, April 1-5, 2006.
Pereira , H.A. Synthetic Cationic Antimicrobial Peptides with Potent Systemic Activities Against Gram Negative Infections. Strategic Research Institute, 11 th Antibacterial Drug Discovery & Development Summit, April 10-11, 2006, Princeton, NJ .

UNIVERSITY GOVERNANCE:

Committees, Boards, Councils:

College

Oklahoma Center for Neuroscience
2005	Judge, Student Presentations, 14th Annual Symposium, Oklahoma City, OK, October 15, 2005
2004	Judge, Student Presentations, 13th Annual Symposium, Oklahoma City, OK, October 14, 2004
2002-present	Board Member, Oklahoma Center for Neuroscience
2001	Organizer, 10th Annual Symposium, Oklahoma Center for Neuroscience (OCNS), “Inflammation in the Central Nervous System”, Oklahoma City, OK, October 5, 2001
2000- 2002	Co-Coordinator, “Neuronights” monthly community outreach program, Oklahoma Center for Neuroscience (OCNS)
2000- 2002	Member, Advisory Committee, Oklahoma Center for Neuroscience (OCNS)
2000- 2002	Member, Executive Committee, Oklahoma Center for Neuroscience (OCNS)
1997-2001	Member, Graduate Education Committee, Oklahoma Center for Neuroscience (OCNS)
1997-2000	Graduate Student Liaison, Graduate Education Committee, Oklahoma Center for Neuroscience (OCNS)

Graduate Program in Biomedical Sciences
2003-2004	Chair, Graduate Education and Curriculum Committee, Graduate Program in Biomedical Sciences (GPiBS)
2002 -present	Member, Graduate Education and Curriculum Committee, Graduate Program in Biomedical Sciences (GPiBS)
1999-2001	Chair, Student Advisory Committee, Graduate Program in Biomedical Sciences (GPiBS)
1999-2000	Member, Graduate Education Committee, Graduate Program in Biomedical Sciences (GPiBS)
1999-2000	Coordinator - Immunology Curriculum, Integrative Biology Course, Graduate Program in Biomedical Sciences (GPiBS)
1998- 2002	Member, Integrated Curriculum Committee, Graduate Program in Biomedical Sciences (GPiBS)

Graduate Student Committees (Non Pathology)
2006-present	Member, Graduate Student exam committee and Thesis Committee for Chris Robinson, Department of Microbiology and Immunology
2006-present	Member, Graduate Student exam committee and Thesis Committee for Jonathn Hunt, Department of Microbiology and Immunology
2005-present	Member, Graduate Student Thesis Committee for Andrea Moyer, Department of Microbiology & Immunology
2005-present	Member, Graduate Student Thesis Committee for Brandt Wiskur, OCNS
2004-present	Member, Graduate Student Thesis Committee for Minyuang Wu, Department of Physiology
2004-present	Member Graduate Student Thesis Committee, Hari Vittal Rao, OCNS
2001-2005	Member, Graduate Student Thesis Committee for Jamee Nixon, Department of Microbiology and Immunology
2001-2004	Member, Graduate Student Thesis Committee for Khaldun Al-Khatib, Department of Microbiology and Immunology
2000-2003	Member, Graduate Student Thesis Committee for Heather Hickman, Department of Microbiology and Immunology
2000-2004	Member, M.D., Ph.D. Student Thesis Committee for Grant Kolar, Department of Microbiology and Immunology
1999-2001	Member, Graduate Student Thesis Committee for Kajetan H. Groicher, Department of Microbiology and Immunology
1998-2000	Member, Graduate Student Thesis Committee for Kasie Nichols, Department of Microbiology and Immunology
1998	Member, Graduate Student Thesis Committee for Scott Hefty, Department of Microbiology and Immunology
1997-2000	Member, Graduate Student Thesis Committee for Sean Bauman, Department of Microbiology and Immunology
1994-1998	Member, Graduate Student Thesis Committee for Hester Doyle, Department of Microbiology and Immunology
1994	Member, Graduate Student Thesis Committee for Christine Roppelt, Department of Microbiology and Immunology
1992-1995	Member, Graduate Student Thesis Committee for Zhao Ming Dong, Department of Microbiology and Immunology
Graduate Education
2006-2008	Member, University Graduate Program Review Committee
2006	Member, Graduate Program Internal Reviewer, Occupation and Environmental Health Program
2006-2007	Vice Chair, OUHSC Graduate Council
2005-2008	Member, OUHSC Graduate Council
1999-2002	Member, OUHSC Graduate Council
1998-1999	Judge, Graduate Research Education and Technology (GREAT-98) (GREAT‑99) Symposia.
1995-1997	Chair, Graduate Council Research Committee-Chair, Graduate Education Research Day, (GERD-95, GERD-96) and Chair, Graduate Research Education and Technology (GREAT-97) Symposium.
1994-present	Member, SURE (Summer Undergraduate Research Experience) Program Selection Committee
1994	Judge, Graduate Education Research Day (GERD)-94

Other
2006-2009	Member, Patient Advisory Committee, College of Medicine representative
2006-2009	Member, Faculty Compensation Committee, College of Medicine representative
2006-2007	Member, Search Committee, Chair, Department of Cell Biology
2006-2007	Alternate Member, Faculty Senate, Representing College of Medicine
2005, 2006	Judge, College of Medicine, GSA Travel Award Competition
2005	Scholarly Misconduct Committee
2005-2006	Alternate Member, representing Graduate Council, Senate
1997-1998	Member, Department of Microbiology & Immunology Search Committee
1997	Member, OUHSC Committee for NIH MARC/U-STAR site visit
1997-1998	Member, Scholarly Misconduct Inquiry Committee
1997	Member, Scientific Equipment Committee/Biomedical Research Center
1996-1998	Member, Library Advisory Committee
1995-1998	Member, Student Awards Committee

Department
2006	Member, Pathology Promotion Advisory Committee
2006	Member, Search Committee, Assistant Professor Comparative Medicine
2005-present	Pathology Graduate Program, Assistant Director
2005	Co-Chair, Search Committee, Chair in Human Genetics , Presbyterian Health Foundation Endowed Chair
2004	Member, Search Committee for Neurovirologist
2003-present	Member, Executive Committee
2002-present	Member, Sponsored Research Committee
2002-2005	Member, Search Committee, Senior Experimental Pathology Position
2001	Chair, Search Committee for Experimental Pathology Position
2000-2001	Director, Pathology Graduate Program
2000	Member, IRB Committee
1998-2001	Member, Promotion & Tenure Sub-committee
1998	Member, Search Committee, Presbyterian Health Foundation Human Genetics Endowed Professorship
1998	Member, Faculty Productivity Committee
1998	Member, Computer Support Committee
1996-present	Member, Adjunct Faculty Appointment Committee
1996-2001	Coordinator, Department of Pathology, Seminar Series
1994-1996	Member, Search Committee, Max Shideler Endowed Professorship
1994-2001	Liaison, Office of Research Administration
1993-present	Member, Graduate Committee, Department of Pathology
1993-2000	Coordinator, Department of Pathology, Common Equipment Room
1993-1994	Member, Summer Fellowship in Pathology Committee
1992-1994	Member, Search Committee for Experimental Pathology Position.
1992-present	Member, Graduate Faculty, College of Medicine

PROFESSIONAL SERVICE:

Service to Professional Societies:

2007	Co-Chair, Symposium “Novel therapies based on molecules of the innate immune system” Experiment Biology, 2007, Washington, DC
2006	Coordinator of SBIR/STTR workshop with OCAST and OUHSC for Dr. Gregory Milman, Director of the Office of Innovation and Special Programs, National Insitutute of Allergy and Infectious Diseases, National Institutes of Health, September 20-21, 2006
2006-2008	American Society for Investigative Pathology (ASIP) Program Committee Member for Experimental Biology (EB 2007 & EB 2008)
2006	Experimental Biology 2006 (EB 2006) - Co-Chair Mini-symposium on Innate and Acquired Immunity
2003	Experiemental Biology 2003 – (EB2003) – Discussion leader, Vascular Wall – Poster/Discussion session
2000	Experimental Biology 2000 (EB2000) Chair - “Mediators of Inflammation” Poster/Discussion Session
1993-1995	American Cancer Society, Oklahoma Division, Professional Education Committee

Grants Review:

National
2001-2002	NIH, Brain Disorders and Clinical Neuroscience BDCN-3 (Ad hoc review)
2001	Maryland Sea Grant, University System of Maryland
1999-2002	American Heart Association, National Immunology & Microbiology I Study Group-Regular Member
1999-present	Alzheimer's Association – Ad hoc Reviewer
1999	NIH, Bioengineering and Physiology, Special Study Section 8
1999	NIH, Brain Disorders and Clinical Neuroscience BDCN-2 (02), Special Emphasis Panel.
1997-present	Department of Veterans Affairs Merit Review Grant Applications - Ad hoc Reviewer
1993-1996	American Cancer Society, Scientific Advisory Committee on Immunology (SAC-IM).

Local
1993, 1996, 1999	University of Oklahoma Medical Alumni Association Research Scholars Committee.
1994-1999	Presbyterian Health Foundation

Ph.D. Thesis Review:

1995	External examiner - Ph.D. Thesis, Fernando Alberdi, Royal Melbourne Institute of Technology (RMIT), Melbourne, Australia

Manuscript Review:

Ad hoc reviewer

American Journal of Pathology
BMC Clinical Pathology
Human Reproduction
Immunology Letters
Infection and Immunity
Journal of Cellular Physiology
Journal of Leukocyte Biology
Journal of Clinical Investigation
Journal of Immunology
Society for Experimental Biology and Medicine

Special Lectures:
Department of Pathology, Academic Rounds, University of Oklahoma Health Sciences Center, Oklahoma City, OK, July 3, 2006. “From bench to bedside: development of a novel antibiotic”

Antibacterial Drug Discovery & Development Summit, Princeton, NJ, April 10-11, 2006. “Synthetic cationic antimicrobial peptides with potent systemic activities against gram negative infections”

Invited speaker, Department of Pathology, Brown University, Providence, RI, February 22, 2006. “Novel antibiotic peptides derived from CAP37, an innate immune system molecule”

Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, October 6, 2005. “The long and tortuous journey from scientific discovery to commercialization. Are we there yet?”

Invited Speaker, Biolife 2005, Oklahoma Life Science Symposium, Oklahoma City, OK, September 13, 2005.

Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, April 7, 2004. “Novel antibiotic peptides derived from CAP37, an innate immune system molecule.”

Department of Pathology, Grand Rounds, University of Oklahoma Health Sciences Center, Oklahoma City, October 14, 2004. “CAP37, a molecule of the innate immune system, its role in vascular disease.”

Inaugural Speaker, “Meet the Scientist” series sponsored by i2E, the Oklahoma Technology Commercialization Center (OTCC) and the Greater Oklahoma City Chamber of Commerce, Presbyterian Health Foundation Conference Center, February 19, 2004, “Natural antibiotics: Prospects for generating novel therapeutics.”

Department of Medicine, Infectious Disease Rounds, University of Oklahoma Health Sciences Center, Oklahoma City, February 11, 2004. “Novel antibiotic peptides based on the neutrophil granule-derived protein CAP37.”

Invited speaker, Baylor College of Medicine, Biology of Inflammation Center, Houston TX. “Gelber Lectureship”, September 4, 2002. “Mechanisms of controlling leukocyte migration to inflamed tissues: the role of CAP37”

Invited speaker, Oklahoma Medical Research Foundation, Oklahoma City OK, Free Radical Biology Program, August 12, 2002. “Is CAP37 a neuroinflammatory mediator?”

Invited Speaker, Oklahoma Center for Neuroscience, Oklahoma City, OK, May 17, 2001. “The neuroinflammatory role of CAP37; a possible role in Alzheimer's disease.”

Invited Speaker, Oklahoma State University, Stillwater, OK., November 13, 2000. “CAP37, a multifunctional inflammatory mediator”.

Invited Lectureship, “Gelber Lecture”, Baylor College of Medicine, Houston, TX, July 11, 2000. “CAP37, a neutrophil-derived multifunctional inflammatory mediator”.

Grand Rounds, University of Oklahoma Health Sciences Center, Oklahoma City, OK, March 29, 2000. “Neuroinflammatory role of CAP37”.

Interdisciplinary Seminar Series, University of Oklahoma Health Sciences Center, Oklahoma City, OK, February 11, 2000. “ Mechanisms controlling leukocyte migration to inflamed tissues: The role of CAP37”.

Plenary Speaker, 7th China & 1st International Symposium on Thrombosis and Hemostasis, Hunan Medical University, Changsha, China, October 7-12, 1999. “CAP37, a multifunctional inflammatory mediator”.

Invited Speaker, The Science Forum A Multi-Disciplinary Conference, Oklahoma Medical Research Foundation, Oklahoma City, OK, June 18, 1998. “Antimicrobial Proteins, Leukocyte Traffic and Endothelium”.

Invited Speaker, American Society for Investigative Pathology, Experimental Biology, 1998, San Francisco, CA, April 18-22, 1998. Special Workshop on Graduate Curricula in Pathobiology “Pathobiology in the 1990s. The University of Oklahoma Health Sciences Center Experience”.

Departmental Seminar, Department of Anatomical Sciences and Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, November 11, 1997. “The many faces of CAP37, a neutrophil-derived multifunctional inflammatory mediator”.

Invited speaker, Laboratory of Molecular Immunoregulation Biological Response Modifiers Program, National Cancer Institute, Frederick, MD. December 13, 1996 “CAP37, a multifunctional inflammatory mediator”.

Departmental Seminar, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, May 24, 1996. “CAP37, an Endogenous LPS Binding Protein”.

NIH Training Program Seminar, Oklahoma Medical Research Foundation, Oklahoma City, OK, November 16, 1995. “CAP37, an endotoxin binding protein from human granulocytes”.

Departmental Seminar, Department of Biological Sciences, University of Tulsa, Tulsa, OK, March 24, 1995. “CAP37, a natural antibiotic and inflammatory mediator”.

Departmental Seminar, Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, April 14, 1994. “CAP37, an Endogenous Inflammatory Mediator and Endotoxin Binding Protein from Human Neutrophils”.

Departmental Seminar, Department of Anatomical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, February 24, 1994. “CAP37, an inflammatory mediator and antibiotic protein from human neutrophils”.

Departmental Seminar, Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, November 22, 1993. “CAP37, an endogenous antibiotic and endotoxin binding peptide”.

NIH Training Program Seminar, Oklahoma Medical Research Foundation, Oklahoma City, OK, October 7, 1993. “Endogenous antibiotic and endotoxin binding peptide”.

Departmental Seminar, Department of Pharmacology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, January 25, 1993. “CAP37, a multifunctional Protein: Its role in host defense and inflammation”.

Departmental Seminar, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, October 9, 1992. “CAP37, an inflammatory mediator and antibiotic protein from human granulocytes”.

NIH Training Program Seminar, Oklahoma Medical Research Foundation, Oklahoma City, OK, October 8, 1992. “CAP37, a multifunctional protein: Its role in host defense and inflammation”.

Departmental Seminar, Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, September 24, 1992. “CAP37, a multifaceted neutrophil protein with diverse host defense functions”.

Second Biotechnology in Infectious Diseases Conference, The Centers for Disease Control, Atlanta, GA, March 18, 1992. “CAP37, an inflammatory mediator and antibiotic protein from human granulocytes”.

Departmental Seminar, Department of Periodontology, Eastman Dental Center, Rochester, NY, February 10, 1992. “CAP37, a multifaceted neutrophil protein with diverse host defense functions”.

Departmental Seminar, Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, January 23, 1992. “CAP37, a neutrophil protein: Its role in host defense and inflammation”.

Departmental Seminar, Department of Microbiology, Texas A & M, College Station, TX, October 1, 1991. “CAP37, a neutrophil protein: Its role in host defense and inflammation”.

Departmental Seminar, Department of Microbiology, University of New Mexico, Albuquerque, NM, September 12, 1991. “CAP37, a multifaceted neutrophil protein with diverse host defense functions.”

Departmental Seminar, Department of Microbiology & Immunology, Emory University, Atlanta, GA, November 30, 1990. “CAP37, a multifaceted neutrophil protein with diverse host defense functions.”

29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston TX, 17-20 September, 1989. “CAP37, a monocyte-specific chemoattractant.”

Scientific Meeting, Royal Children's Hospital, Melbourne, Australia, 13 April, 1984 - “Opsonins - the link between microorganisms and defense mechanisms.”

Professional service to the community:

2004	Oklahoma Innovations Radio Broadcast (KTOK), March 8, 2004
2001	Oklahoma Innovations Radio Broadcast (KTOK), Speaker, March, September
1999	National Association of Retired Federal Employees-Alzheimer's Awareness Month, Luncheon Speaker
1998	American Heart Association, Oklahoma Affiliate Teleparty fund raising event
1996	Alzheimer's Association “Library Series” speaker, Edmond Public Library, OK, November 18, 1996
1996	American Cancer Society, Canadian County Division 2nd Relay for Life, Master of Ceremonies, June 14, 1996
1995	High School Science Club Day
1995-2002	Review Applicants for Oklahoma School of Science and Mathematics
1993-1996	Firehouse Art Center, Norman, OK, Volunteer

OTHER:

Patents:

Click on Serial Number* to view individual abstracts as recorded at the U.S. Patent and Trademark Office (www.uspto.gov).*
U.S. Ser. No.	07/855,417
Filed:	March 19, 1992
Patent No.	5,484,855
Issued:	January 16, 1996
Entitled:	Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37
Inventors:	H.A. Pereira and J.K. Spitznagel

U.S. Ser. No.	07/969,931
Filed:	October 30, 1992
Patent No.	5,458,874
Issued:	October 17, 1995
Entitled:	Method of increasing monocyte chemotaxis with CAP37 and monocyte chemotactic portions thereof
Inventors:	H.A. Pereira and J.K. Spitznagel

U.S. Ser. No.	08/235,399
Filed:	April 29, 1994
Patent No.	5,607,916
Issued:	March 4, 1997
Entitled:	Method and composition for the treatment of septic shock
Inventors:	H.A. Pereira, D.J. Brackett and M.R. Lerner

U.S. Ser. No.	08/455,485
Filed:	May 31, 1995
Patent No.	5,650,392
Issued	July 22, 1997
Entitled:	Method and composition for the treatment of septic shock
Inventors:	H.A. Pereira, D.J. Brackett and M.R. Lerner

U.S. Ser. No.	08/482,328
Filed:	June 7, 1995
Patent No.	5,627,262
Issued:	May 6, 1997
Entitled:	Method and composition for the treatment of septic shock
Inventor:	H.A. Pereira

U.S. Ser. No.	08/840,519
Filed:	April 21, 1997
Patent No.	5,877,151
Issued:	March 2, 1999
Entitled:	Method for inhibiting production of tumor necrosis factor
Inventor:	H.A. Pereira

U.S. Ser. No.	09/260,373
Filed:	March 1, 1999
Patent No.	6,071,879
Issued:	June 6, 2000
Entitled:	Method for treatment of bacterial infection
Inventor:	H.A. Pereira

U.S. Ser. No.	09/258,934
Filed:	March 1, 1999
Patent No.	6,107,460
Issued:	August 22, 2000
Entitled:	Antimicrobial peptides and methods of use thereof
Inventor:	H. A. Pereira

U.S. Ser. No.	Divisional of 09/258,934
Filed:	July 19, 2000
Patent No.	6,514,701
Issued:	February 4, 2003
Entitled:	Antimicrobial peptides and methods of use thereof
Inventor:	H. A. Pereira

U.S. Ser. No.	Divisional of 60/363,114
Filed:	March 7, 2003
Patent no.	Pending
Entitled:	An early detection marker for chronic inflammatory associated diseases
Inventor:	H. A. Pereira

U.S. Ser. No.	Divisional of 60/378,295
Filed:	April 28, 2003
Patent No.	Pending
Entitled:	Treatment and inhibition of ocular infections and wounds by CAP37 and CAP37 peptides
Inventors:	H. A. P ereira, J. Chodosh, and M. C. Callegan

U.S. Ser. No.	10/328,125
Filed:	December 12, 2002
Patent no.	6,730,659
Issued:	May 3, 2004
Entitled:	Antimicrobial peptides and methods of use thereof
Inventor:	H. A. Pereira

U.S. Ser. No.	Unknown
Filed:	August 1, 2005
Patent no.	Pending
Entitled:	Antifungal peptides and methods of us thereof
Inventors:	H.A. Pereira and Paul L. Fidel, Jr.

Press Coverage

Clay D, "Research team hopes to ward off infections", The Oklahoman , Tuesday, February 3, 2004, 3D.

Buckelew A, "Antibiotic resistant bacteria & CAP37," KWTV NEWS 9 "Medical Minute", Monday, February 9, 2004.

Oklahoma Technology Commercialization Center, Meet the Scientist Luncheon , Wednesday, February 19, 2004.

Stafford J, "State biotechs venture west for investor confidence", The Oklahoman, Tuesday, June 8, 2004, 1B (Dr. Pereira's comments are on page two of the linked document)

Feature article in "A day in the life of a scientist", Future Value, Winter 2004

Stafford J, "Seed money is sought for startups", The Oklahoman, Wednesday, September 14, 2005.

Martinelli DL, "Hope for Patients at Risk", Sooner Magazine, Spring 2007, Vol 27 No 3, 9-11.

Walker T, "Anne Pereira is on a Scientific Search to Battle Antibiotic Resistant Bacteria", distinctly Oklahoma, April 2008, 76-79.